Capital Raising 2026
An overview of emerging fundraising mechanisms and institutional investor expectations for 2026.
As financing markets are being reshaped, French and European SMEs and mid-caps must now diversify their capital sources well beyond traditional models. This study examines the concrete levers (private debt, hybrid financing, patient capital) that structure successful fundraising operations in 2026.
« Companies that diversify their financing sources before they need to negotiate from a position of strength, not urgency. »
SFDS Research · Studies & Insights teamAccess to bank credit has tightened since 2024, pushing a growing number of companies to explore structured alternatives. This first section sets the macroeconomic backdrop and presents the trends observed over the past twelve months among a panel of one hundred companies supported by SFDS.
Private debt, unitranche, convertible bonds, patient capital: we map the instruments gaining ground and detail their eligibility conditions, real cost and impact on the borrowing company's governance.
Discover our full analysis, data, recommendations and perspectives.